[go: up one dir, main page]

AU2001280754A1 - Enhancement of photodynamic therapy by anti-angiogenic treatment - Google Patents

Enhancement of photodynamic therapy by anti-angiogenic treatment

Info

Publication number
AU2001280754A1
AU2001280754A1 AU2001280754A AU8075401A AU2001280754A1 AU 2001280754 A1 AU2001280754 A1 AU 2001280754A1 AU 2001280754 A AU2001280754 A AU 2001280754A AU 8075401 A AU8075401 A AU 8075401A AU 2001280754 A1 AU2001280754 A1 AU 2001280754A1
Authority
AU
Australia
Prior art keywords
enhancement
photodynamic therapy
angiogenic treatment
angiogenic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280754A
Inventor
Parkash S Gill
Charles J. Gomer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Publication of AU2001280754A1 publication Critical patent/AU2001280754A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001280754A 2000-07-24 2001-07-24 Enhancement of photodynamic therapy by anti-angiogenic treatment Abandoned AU2001280754A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22031100P 2000-07-24 2000-07-24
US60220311 2000-07-24
PCT/US2001/023324 WO2002007819A1 (en) 2000-07-24 2001-07-24 Enhancement of photodynamic therapy by anti-angiogenic treatment

Publications (1)

Publication Number Publication Date
AU2001280754A1 true AU2001280754A1 (en) 2002-02-05

Family

ID=22823035

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280754A Abandoned AU2001280754A1 (en) 2000-07-24 2001-07-24 Enhancement of photodynamic therapy by anti-angiogenic treatment

Country Status (3)

Country Link
US (1) US20020026945A1 (en)
AU (1) AU2001280754A1 (en)
WO (1) WO2002007819A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100326A2 (en) * 2001-05-01 2002-12-19 The General Hospital Corporation Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
CA2530166A1 (en) * 2003-03-07 2004-09-23 Randolph D. Glickman Antibody-targeted photodynamic therapy
WO2004099375A2 (en) * 2003-04-30 2004-11-18 The General Hospital Corporation Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof
TW200610555A (en) * 2004-09-24 2006-04-01 Light Sciences Corp Extended treatment of tumors through vessel occlusion with light activated drugs
US20060084951A1 (en) * 2004-10-05 2006-04-20 Heacock Gregory L Low energy of excitation PDT compounds for treatment of ocular disease
WO2009102960A1 (en) * 2008-02-15 2009-08-20 Board Of Regents Of The University Of Texas System Compositions and methods for treating lung cancer
US20100010482A1 (en) * 2008-06-23 2010-01-14 Ceramoptec Industries Inc. Enhanced Photodynamic Therapy Treatment and Instrument
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
EP2968374A4 (en) * 2013-03-15 2016-08-10 Alphabet 3 Llc M Methods and compositions for enhancing oxygen levels in tissues

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
US5837283A (en) * 1997-03-12 1998-11-17 The Regents Of The University Of California Cationic lipid compositions targeting angiogenic endothelial cells

Also Published As

Publication number Publication date
US20020026945A1 (en) 2002-03-07
WO2002007819A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2001282717A1 (en) Cancer treatment by combination therapy
AU2001294604A1 (en) Improved radiation therapy treatment method
AUPR406501A0 (en) Treatment of vault prolapse
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
AU2002257936A1 (en) Methods of well treatment
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
AU2002252415A1 (en) Treatment of lipid pool
IL164599A0 (en) Combination therapy for the treatment of cancer
AU2002252456A1 (en) Combination treatment of pancreatic cancer
IL158329A0 (en) Antiangiogenic combination therapy for the treatment of cancer
HUP0500424A3 (en) Combination therapy for the treatment of cancer
AUPQ923100A0 (en) Treatment of prostate cancer
AUPQ515000A0 (en) Treatment of uv induced immunosuppression
AU2001280754A1 (en) Enhancement of photodynamic therapy by anti-angiogenic treatment
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
AU5000001A (en) Treatment of vitiligo
MXPA03007036A (en) Method of cancer therapy.
HRP20020729A2 (en) Treatment of psoriasis
AU2002350959A1 (en) Water treatment using ferrate
GB0124124D0 (en) Methods of treatment
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU3567500A (en) Photodynamic therapy compounds
AU2001281465A1 (en) Treatment of rosacea
AU2002343495A1 (en) Magnetic field enhancement of tumor treatment
AU2002346661A1 (en) Photodynamic therapy for the treatment of epilepsy